Organogenesis Holdings Inc (ORGO)
4.00
-0.43
(-9.71%)
USD |
NASDAQ |
Nov 14, 16:00
4.00
0.00 (0.00%)
After-Hours: 19:50
Organogenesis Holdings Shareholders Equity (Quarterly): 263.50M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 263.50M |
| March 31, 2024 | 278.03M |
| December 31, 2023 | 278.66M |
| September 30, 2023 | 276.86M |
| June 30, 2023 | 271.28M |
| March 31, 2023 | 263.70M |
| December 31, 2022 | 265.67M |
| September 30, 2022 | 256.33M |
| June 30, 2022 | 254.38M |
| March 31, 2022 | 243.23M |
| December 31, 2021 | 241.34M |
| September 30, 2021 | 189.17M |
| June 30, 2021 | 178.92M |
| March 31, 2021 | 157.29M |
| December 31, 2020 | 141.81M |
| September 30, 2020 | 65.47M |
| June 30, 2020 | 35.75M |
| Date | Value |
|---|---|
| March 31, 2020 | 40.30M |
| December 31, 2019 | 55.58M |
| September 30, 2019 | 12.81M |
| June 30, 2019 | 23.20M |
| March 31, 2019 | 32.56M |
| December 31, 2018 | 47.04M |
| September 30, 2018 | 303.17M |
| June 30, 2018 | 298.24M |
| March 31, 2018 | 297.88M |
| December 31, 2017 | -8.555M |
| September 30, 2017 | 298.51M |
| June 30, 2017 | 300.63M |
| March 31, 2017 | 300.25M |
| December 31, 2016 | 300.11M |
| September 30, 2016 | -0.0307M |
| June 30, 2016 | -0.0162M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
35.75M
Minimum
Jun 2020
278.66M
Maximum
Dec 2023
197.75M
Average
243.23M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Poseida Therapeutics Inc | 60.82M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 443.16M |
| Total Liabilities (Quarterly) | 179.66M |
| Debt to Equity Ratio | 0.2409 |
| Current Ratio | 2.732 |
| Net Debt Paydown Yield | 0.34% |